What Is Journavx, A New Non-opioid Pain Reliever Approved By FDA in Decades?
The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.
Hosted on MSN35m
India Battles Guillain-Barré Syndrome, Maharashtra Logs 130 Fresh Cases, 4 Deaths; Uganda Reports New Ebola Outbreak
As health concerns intensify across nations, India is facing a growing crisis with Guillain-Barr Syndrome, with 130 reported ...